According to a report from bwhealthcareworld, a health website, India is home to one hundred million smokers, accounting for over 20% of tobacco-related deaths worldwide and negatively impacting families, livelihoods, and national productivity. Medical experts in India emphasize the importance of easily accessing nicotine replacement therapy (NRT) as an effective tool in aiding individuals to quit smoking.
Nicotine Replacement Therapy (NRT) has become a pivotal treatment method.
According to a recent report, experts believe that a comprehensive tobacco control strategy is crucial to address the issue of tobacco addiction in India, which causes over one million deaths annually, accounting for 9.5% of the total national mortality. This strategy should include improving the accessibility of tobacco cessation methods, public education, and the use of approved therapies such as Nicotine Replacement Therapy (NRT). Playing a pivotal role in this battle, NRT has a 25-year history of usage and has been found to increase the success rate of quitting smoking by 50% compared to unassisted attempts.
Dr. Chandrakant S Pandav, former head of the Department of Community Medicine at the All India Institute of Medical Sciences and recipient of the Padma Shri Award, emphasizes the urgent need to improve the avenues through which the Indian public can access tobacco cessation methods.
He stated that 28.6% of adults in India smoke, and these challenges are more persistent in remote and rural areas. Therefore, "NRT should be made available over the counter at pharmacies. Easy access increases the likelihood of successful smoking cessation.
Integrated therapy combining psychology and physiology is needed.
Unlike nicotine in cigarettes, NRT (Nicotine Replacement Therapy) provides a temporary substitute for nicotine, helping to control cravings, alleviate withdrawal symptoms, and facilitate the transition to a tobacco-free life. NRT ensures a gradual and controlled increase in nicotine levels in the bloodstream, preventing abuse.
Dr. Sajeela Maini, an expert in tobacco cessation, alcohol cessation, and mental health at Gangaram Hospital in New Delhi, stated, "Substituting nicotine products for cigarettes is the most effective method for reducing cravings and withdrawal symptoms. We must address the psychological and physiological aspects of tobacco addiction in order to ensure successful smoking cessation.
However, the proposal put forward by the Indian Drugs Technical Advisory Board to change over-the-counter sales of NRT to prescription-only has sparked intense debate within the academic community. They argue that such a move could potentially reverse progress made in combating tobacco addiction and goes against recommendations by major global health authorities. Medical experts advocating for NRT emphasize that classifying tobacco as a prescription drug would limit the access for individuals seeking to quit smoking, hindering the government's goals for tobacco cessation.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
